This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

DKA

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Diabetic ketoacidosis (DKA) is defined by the biochemical triad of ketonaemia, hyperglycaemia and acidaemia (1).

DKA may result from:

  • absolute deficiency of circulating insulin e.g. -
    • previously undiagnosed type 1 diabetes mellitus
    • patients who do not take insulin deliberately or inadvertently (especially the long acting component of a basal-bolus regimen)
  • relative deficiency
    • caused by increased levels of the counter regulatory hormones: catecholamines, glucagon, cortisol and growth hormone as a response to tress in conditions such as sepsis, trauma, or gastrointestinal illness with diarrhea and vomiting etc. despite taking the usual recommended dose of insulin (2)

DKA is thought to be indicative, or even diagnostic, of type 1 diabetes, but increasingly there are cases of ketone-prone type 2 diabetes being recognised (3).

  • patients with type 2 diabetes who have ketosis-prone diabetes represents 20 to 50 % of persons with DKA (these patients have impaired insulin secretion)

It should be regarded a medical emergency; its rapid recognition and accurate treatment are essential to prevent morbidity and mortality.

It should be noted that there are subtle differences in the management in children and in adults.

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.